Olivier Delporte

Olivier is CEO of Miracor Medical Systems, a company which aims at heart failure prevention with its PiCSO therapy. Prior to Miracor Medical, Olivier was SVP Commercial at PneumRx (acquired by BTG in 2015) and before this he led the commercial operations of Tryton Medical outside the US. Prior to Tryton Medical, Olivier held management positions at Guidant and Abbott Vascular. Olivier is also a director of Cardiatis, a manufacturer of endovascular devices to treat aneurysms and dissections.